In The News

Bone Health Technologies Raises $2.5M In New Funding Round, Adds 3 Members To Board Bone Health Technologies, a MedTech company focused on treating osteoporosis, announced the completion of a new funding round and the appointment of new board members. Funding Secured: San Francisco, California-based Bone Health said it has closed a $2.5 million funding round. The company noted the funding was oversubscribed. Good Growth Capital led the funding round with…
Read more

Laura Yecies | OsteoBoost: A Vibration Belt to Prevent Osteoporosis

Interview with CEO Laura Yecies on Happy Bones, Happy Life podcast!

Health Tech Spotlight: Laura Yecies – CEO at Bone Health Technologies

CEO Laura Yecies is interviewed about how their easy-to-use medical device can prevent osteoporosis, winning the One Harvard New Venture Competition, and playing the violin!


“In terms of research funding, we have nothing to complain about — we have benefited from very generous grants — and what I find in my fundraising (is) if it’s a male audience where they don’t have a lot of domain expertise, they don’t get it,” Yecies said. “But it resonates with women, and I am getting more interest from women investors, angel investors and VC firms led by women.”

ViewPoints Interview: BoneHealth Technologies’ Laura Yecies Shares Insights on OsteoBoost Vibration Belt

In a recent interview with PharmaShots, Laura Yecies, CEO of BoneHealth Technologies shared her views on OsteoBoost Vibration Belt that has been granted “Breakthrough Device” designation by the US FDA.

FDA breakthrough device designation strengthens Osteoboost outlook

Bone Health Technologies Inc. may be on the verge of upstaging a common drug therapy, but don’t tell them to break a leg. The San Francisco-based company’s Osteoboost Vibration Belt received a U.S. FDA breakthrough designation for technology that delivers gentle stimulation to reduce bone loss and prevent osteoporosis with the goal of reducing the number of potentially devastating broken bones in the elderly.

Vibrating Belt Gets FDA ‘Breakthrough Device’ Designation for Osteoporosis

The U.S. Food and Drug Administration has given “Breakthrough Device” designation to a vibrating belt that lowers the risk of bone fractures caused by osteoporosis.

FDA grants breakthrough device designation to osteoporosis ‘vibration belt’

FDA grants breakthrough device designation to a belt that uses proprietary vibration technology to stop the progression of bone loss and prevent the onset of osteoporosis.